{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:40:59Z","timestamp":1779255659618,"version":"3.51.4"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101753"],"award-info":[{"award-number":["82101753"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Genetic kidney disease is a major cause of morbidity and mortality in neonates and end-stage renal disease (ESRD) in children and adolescents. Genetic diagnosis provides key information for early identification of congenital kidney disease and reproductive risk counseling. Preimplantation genetic testing for monogenic disease (PGT-M) as a reproductive technology helps prospective parents to prevent passing on disease-causing mutations to their offspring.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>A retrospective cohort of couples counseled on PGT who had a risk to given birth to a child with genetic kidney disease or had a history of prenatal fetal kidney and urinary system development abnormalities from 2011 to 2021. Through a combination of simultaneously screening for aneuploidy and monogenic kidney disease, we achieved reproductive genetic intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 64 couples counseled on PGT for monogenic kidney disease in a single reproductive center during the past 10 years, of whom 38 different genetic kidney diseases were identified. The most frequent indications for referral were autosomal recessive disease (54.7%), then autosomal dominant disease (29.7%), and X-linked disease (15.6%). Polycystic kidney disease was the most common diseases counted for 34.4%. After oocyte-retrieval in all of 64 females, a total of 339 embryos were diagnosed and 63 embryos were transferred in succession. Among 61 cycles of frozen-embryo transfer (FET), ongoing pregnancy\/live birth rate (OP\/LBR) reached 57.38%. The cumulative OP\/LBR in our cohort for the 64 couples was 54.69%. In addition, we have carried out expanded carrier screening (ECS) in all the <jats:italic>in vitro<\/jats:italic> fertilization (IVF) couples performed PGT covering 7,311 individuals. The carrier frequency of the candidate genes for monogenic kidney diseases accounted for 12.19%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Overall, the customization PGT-M plan in our IVF center is pivotal to decreasing the morbidity and implementing reproductive genetic intervention of genetic kidney disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.936578","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T05:12:53Z","timestamp":1655442773000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Combined Preimplantation Genetic Testing for Genetic Kidney Disease: Genetic Risk Identification, Assisted Reproductive Cycle, and Pregnancy Outcome Analysis"],"prefix":"10.3389","volume":"9","author":[{"given":"Min","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saijuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caixia","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s43657-021-00014-1","article-title":"Genetic architecture of childhood kidney and urological diseases in China.","volume":"1","author":"Fang","year":"2021","journal-title":"Phenomics."},{"key":"B2","doi-asserted-by":"publisher","first-page":"728548","DOI":"10.3389\/fped.2021.728548","article-title":"Risk factors associated with renal and urinary tract anomalies delineated by an ultrasound screening program in infants.","volume":"9","author":"Liu","year":"2022","journal-title":"Front Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2215\/CJN.03550320","article-title":"Preimplantation genetic testing for monogenic kidney disease.","volume":"15","author":"Snoek","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"hoaa020","DOI":"10.1093\/hropen\/hoaa020","article-title":"ESHRE PGT consortium and SIG embryology good practice recommendations for polar body and embryo biopsy for PGT.","volume":"2020","author":"Kokkali","year":"2020","journal-title":"Hum Reprod Open."},{"key":"B5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/pd.1970150409","article-title":"Normal pregnancy after preimplantation DNA diagnosis of a dystrophin gene deletion.","volume":"15","author":"Liu","year":"1995","journal-title":"Prenat Diagn."},{"key":"B6","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1159\/000518253","article-title":"Preimplantation genetic testing for kidney disease-related genes: a laboratory\u2019s experience.","volume":"52","author":"Chaperon","year":"2021","journal-title":"Am J Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/humrep\/dez027","article-title":"Factors influencing the clinical outcome of preimplantation genetic testing for polycystic kidney disease.","volume":"34","author":"Berckmoes","year":"2019","journal-title":"Hum Reprod."},{"key":"B8","doi-asserted-by":"publisher","first-page":"633003","DOI":"10.3389\/fgene.2021.633003","article-title":"Case report: preimplantation genetic testing and pregnancy outcomes in women with alport syndrome.","volume":"12","author":"Shi","year":"2021","journal-title":"Front Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"A19","DOI":"10.1530\/REP","article-title":"Single-cell technologies at the forefront of PGT and embryo research.","volume":"160","author":"T\u0161uiko","year":"2020","journal-title":"Reproduction."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s10815-020-01846-y","article-title":"Complex preimplantation genetic tests for Robertsonian translocation, HLA, and X-linked hyper IgM syndrome caused by a novel mutation of CD40LG gene.","volume":"37","author":"Huang","year":"2020","journal-title":"J Assist Reprod Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1340","DOI":"10.1002\/mgg3.1340","article-title":"Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technology.","volume":"8","author":"Xi","year":"2020","journal-title":"Mol Genet Genomic Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/humrep\/deq231","article-title":"ESHRE PGD consortium best practice guidelines for amplification-based PGD.","volume":"26","author":"Harton","year":"2011","journal-title":"Hum Reprod."},{"key":"B13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jmoldx.2021.02.011","article-title":"Next-generation sequencing is more efficient at detecting mosaic embryos and improving pregnancy outcomes than single-nucleotide polymorphism array analysis.","volume":"23","author":"Xiao","year":"2021","journal-title":"J Mol Diagn."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/bioinformatics\/btq330","article-title":"Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor.","volume":"26","author":"McLaren","year":"2010","journal-title":"Bioinformatics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans.","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the association for molecular pathology, American society of clinical oncology, and college of American pathologists.","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn."},{"key":"B18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","article-title":"ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007.","volume":"10","author":"Richards","year":"2008","journal-title":"Genet Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature13127","article-title":"Guidelines for investigating causality of sequence variants in human disease.","volume":"508","author":"MacArthur","year":"2014","journal-title":"Nature."},{"key":"B20","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS Recommendations for the description of sequence variants: 2016 update.","volume":"37","author":"den Dunnen","year":"2016","journal-title":"Hum Mutat."},{"key":"B21","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/gim.2014.45","article-title":"Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro.","volume":"16","author":"Natesan","year":"2014","journal-title":"Genet Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/humupd\/dmu016","article-title":"The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans.","volume":"20","author":"Taylor","year":"2014","journal-title":"Hum Reprod Update."},{"key":"B23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-genet-041720-093403","article-title":"Mosaicism in human health and disease.","volume":"54","author":"Thorpe","year":"2020","journal-title":"Annu Rev Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.fertnstert.2014.07.1207","article-title":"Blastocyst euploidy and implantation rates in a young (<35 years) and old (\u226535 years) presumed fertile and infertile patient population.","volume":"102","author":"Taylor","year":"2014","journal-title":"Fertil Steril."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1097\/AOG.0000000000001951","article-title":"Committee opinion no. 690: carrier screening in the age of genomic medicine. Obstet Gynecol.","volume":"129","year":"2017"},{"key":"B26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10815-022-02398-z","article-title":"Carrier screening and PGT for an autosomal recessive monogenic disorder: insights from virtual trials.","volume":"39","author":"Scriven","year":"2022","journal-title":"J Assist Reprod Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3390\/jcm9030751","article-title":"Targeted exome sequencing provided comprehensive genetic diagnosis of congenital anomalies of the kidney and urinary tract.","volume":"9","author":"Ahn","year":"2020","journal-title":"J Clin Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000506803","article-title":"Closed vs. Open oocyte vitrification methods are equally effective for blastocyst embryo transfers: prospective study from a sibling oocyte donation program.","volume":"85","author":"Gullo","year":"2020","journal-title":"Gynecol Obstet Invest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"12248","DOI":"10.3390\/ijms222212248","article-title":"Fertility sparing treatments in endometrial cancer patients: the potential role of the new molecular classification.","volume":"22","author":"Cavaliere","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"11825","DOI":"10.3390\/ijms222111825","article-title":"Fertility-sparing approach in women affected by stage I and low-grade endometrial carcinoma: an updated overview.","volume":"22","author":"Gullo","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/cge.13871","article-title":"A novel monogenic preimplantation genetic testing strategy for sporadic polycystic kidney caused by de novo PKD1 mutation.","volume":"99","author":"Shi","year":"2021","journal-title":"Clin Genet."},{"key":"B32","doi-asserted-by":"crossref","first-page":"743150","DOI":"10.3389\/fmed.2021.743150","article-title":"Mosaic PKHD1 in polycystic kidneys caused aberrant protein expression in the mitochondria and lysosomes.","volume":"8","author":"Xu","year":"2021","journal-title":"Front Med (Lausanne)."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.936578\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T05:12:58Z","timestamp":1655442778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.936578\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":32,"alternative-id":["10.3389\/fmed.2022.936578"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.936578","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]},"article-number":"936578"}}